Prognostic performance of pancreatic stone protein in critically ill patients with sepsis. Author: Guadiana-Romualdo

Abstract

Aim: To assess the prognostic value for 28-day mortality of PSP in critically ill patients with sepsis. 

Material & methods: 122 consecutive patients with sepsis were enrolled in this study. Blood samples were collected on admission and day 2. 

Results: On admission, the combination of PSP and lactate achieved an area under the receiver operating characteristic (AUC-ROC) of 0.796, similar to sequential organ failure assessment score alone (AUC-ROC: 0.826). On day 2, PSP was the biomarker with the highest performance (AUC-ROC: 0.844), although lower (p = 0.041) than Sequential organ failure assessment score (AUC-ROC: 0.923).

Conclusion

The combination of PSP and lactate and PSP alone, on day 2, have a good performance for prognosis of 28-day mortality and could help to identify patients who may benefit most from tailored intensive care unit management.